Award
National Institute on Drug Abuse 5R34DA057165-03
Long-acting injectable antiretroviral treatment to improve HIV treatment among justice-involved persons being released to the community
Recipient
Miriam Hospital
Award Amount
$231,115.00
Ceiling
$231,115.00
Awarded
August 02, 2024
Identifier
5R34DA057165-03
NIH awarded $231,115 to Miriam Hospital for a study on long-acting injectable HIV treatment to improve outcomes among justice-involved persons being released to the community in Baltimore, Maryland. The project involves a pilot randomized controlled trial with 50 participants focusing on HIV viral suppression and treatment adherence.
Description
This study aims to investigate whether recently approved long-acting injectable HIV treatment can improve HIV treatment outcomes among persons being released from correctional facilities. The focus is on community re-entry, a high-risk period for HIV treatment adherence. The study is a mixed methods, pilot, and randomized controlled trial conducted in the Baltimore Metropolitan area, Maryland, with collaborators including Maryland Department of Public Safety and Correctional Services, Corizon Health, and Total Health Care. The primary outcome is HIV viral suppression, with secondary outcomes including ART adherence, substance use, and retention in care. The pilot RCT will include 50 participants.